The risk of melanoma appears to be higher in RA patients compared to the general population regardless of whether they’ve been treated with anti-TNFs, data from ARAD shows. Presenting the findings at a session on biologics registries Professor Lyn March said it was probably the rheumatoid arthritis status itself, and possibly methotrexate exposure, that increased skin ...
Biologics not causing elevated skin cancer risk in RA: ARAD
By Nicola Garrett
24 May 2015